Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Entrada Therapeutics | TRDA | Jan 17, 2025 | 12.69 | +1.20 |
Entravision Communications | EVC | Jan 17, 2025 | 2.36 | +2.61 |
Envela | ELA | Jan 17, 2025 | 7.13 | +0.85 |
Enveric Biosciences | ENVB | Jan 17, 2025 | 0.35 | +1.11 |
Enviri | NVRI | Jan 17, 2025 | 8.62 | -0.35 |
Environmental Svcs ETF Market Vectors | EVX | Jan 17, 2025 | 177.63 | +0.04 |
Envirotech Vehicles | EVTV | Jan 17, 2025 | 1.06 | -6.19 |
Envista | NVST | Jan 17, 2025 | 19.83 | +3.34 |
Envoy Medical A | COCH | Jan 17, 2025 | 1.41 | -6.00 |
enVVeno Medical | NVNO | Jan 17, 2025 | 3.29 | +3.46 |
Enzo Biochem | ENZ | Jan 17, 2025 | 0.66 | -1.50 |
EOG Resources | EOG | Jan 17, 2025 | 136.58 | -1.06 |
EON Resources A | EONR | Jan 17, 2025 | 1.02 | +4.60 |
Eos Energy Enterprises | EOSE | Jan 17, 2025 | 6.02 | -2.27 |
EPAM Systems | EPAM | Jan 17, 2025 | 229.08 | 0.00 |
EpicQuest Eduaction Group | EEIQ | Jan 17, 2025 | 1.01 | -2.32 |
ePlus | PLUS | Jan 17, 2025 | 80.06 | -0.09 |
EPR Properties | EPR | Jan 17, 2025 | 46.85 | +0.43 |
EPR Properties Pref C | EPR-C | Jan 17, 2025 | 21.50 | -0.28 |
EPR Properties Pref E | EPR-E | Jan 17, 2025 | 28.18 | +1.04 |
EPR Properties Pref G | EPR-G | Jan 17, 2025 | 20.18 | -0.10 |
Epsilon Energy | EPSN | Jan 17, 2025 | 6.61 | +2.01 |
EQT | EQT | Jan 17, 2025 | 52.96 | -1.52 |
Equifax | EFX | Jan 17, 2025 | 262.87 | -0.52 |
Equillium | EQ | Jan 17, 2025 | 0.64 | -8.00 |
Equinix | EQIX | Jan 17, 2025 | 915.59 | -0.47 |
Equinor ADR | EQNR | Jan 17, 2025 | 24.92 | -0.56 |
Equinox Gold | EQX | Jan 17, 2025 | 5.84 | -0.34 |
Equitable A Pref | EQH-A | Jan 17, 2025 | 20.90 | -0.38 |
Equitable C Pref | EQH-C | Jan 17, 2025 | 18.03 | +0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.